<DOC>
	<DOCNO>NCT00665366</DOCNO>
	<brief_summary>The purpose study determine whether aripiprazole provide additional clinical benefit patient Bipolar I disorder combined lithium valproate 12 week .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Aripiprazole Administered With Lithium Valproate Over 12 Weeks Treatment Mania Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Key inclusion criterion : Clinical diagnosis bipolar I disorder mania , manic mixed episode , without psychotic feature Current ongoing lithium valproate treatment possibility benefiting , base investigator 's clinical judgment , adjunctive treatment aripiprazole Therapeutic serum level lithium valproate Young Mania Rating Total Score 16 high screening baseline Participants take current lithium valproate treatment combine antipsychotic medication aripiprazole acceptable , provide antipsychotic medication wash least 3 day prior blood draw therapeutic plasma level lithium valproate determination . Longacting antipsychotic must wash prior enter doubleblind treatment . Key exclusion criterion : Women childbearing potential unwilling unable use acceptable method avoid pregnancy entire study period 4 week last dose investigational product A diagnosis delirium , dementia , amnesia cognitive disorder , psychotic disorder Current diagnosis delirium , dementia , cognitive disorder ( ie , amnesia ) , psychotic disorder ( ie , schizophrenia schizoaffective disorder ) Current diagnosis bipolar II disorder , bipolar disorder otherwise specify , primary psychiatric disorder bipolar I disorder mania Thyroid pathology Demonstrated cocaine abuse dependence within past 3 month prior screen . History neuroleptic malignant syndrome antipsychotic agent Manic symptom investigator considers refractory treatment Previous nonresponsive ( investigator judgment ) aripiprazole manic symptom Significant risk suicide base history , mental status exam , investigator judgment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>